Evidence map›Paper›PMID 35705974›Full record

ArticleJournal of nanobiotechnology2022

Microbial hydrogen "manufactory" for enhanced gas therapy and self-activated immunotherapy via reduced immune escape.

Hongyu Yan, Miao Fan, Huifang Liu, Tingshan Xiao, Dandan Han, Ruijun Che, Wei Zhang, Xiaohan Zhou, June Wang, Chi Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Hongyu YanDongguan Institute of Clinical Cancer Research, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, 523059, China.
Miao FanCollege of Chemistry & Environmental Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, Hebei University, Baoding, 071002, People's Republic of China.
Huifang LiuCollege of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, 071002, People's Republic of China.
Tingshan XiaoCollege of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, 071002, People's Republic of China.
Dandan HanCollege of Chemistry & Environmental Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, Hebei University, Baoding, 071002, People's Republic of China.
Ruijun CheCollege of Chemistry & Environmental Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, Hebei University, Baoding, 071002, People's Republic of China.
Wei ZhangDepartment of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth Peoples' Hospital, 600 Yishan Road, Shanghai, 200233, China.
Xiaohan ZhouDongguan Institute of Clinical Cancer Research, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, 523059, China.
June WangDongguan Institute of Clinical Cancer Research, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, 523059, China.
Chi ZhangDepartment of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth Peoples' Hospital, 600 Yishan Road, Shanghai, 200233, China.
Xinjian YangCollege of Chemistry & Environmental Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, Hebei University, Baoding, 071002, People's Republic of China.
Jinchao ZhangCollege of Chemistry & Environmental Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, Hebei University, Baoding, 071002, People's Republic of China. jczhang6970@163.com.
Zhenhua LiDongguan Institute of Clinical Cancer Research, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, 523059, China. zhenhuali@hbu.edu.cn.ORCID http://orcid.org/0000-0001-9751-0864
Hebei University · CNShanghai Jiao Tong University · CNSouthern Medical University · CNDongguan People’s Hospital · CN

Funding

Beijing-Tianjin-Hebei Basic Research Cooperation Project 19JCZDJC64100Cross-Disciplinary Project of Hebei University DXK201916National Natural Science Foundation of China 21601046National Natural Science Foundation of China 21977024National Natural Science Foundation of China 31971304One Hundred Talent Project of Hebei Province E2018100002Science Fund for Creative Research Groups of Nature Science Foundation of Hebei Province B2021201038
6 · The paper itself

Abstract

backgroundAs an antioxidant, hydrogen (H

resultsPhotosynthetic bacteria (PSB) release a large amount of hydrogen to break the balance of oxidative stress. In addition, as a nontoxic bacterium, PSB could stimulate the immune response and increase the infiltration of CD4+ and CD8+ T cells. More interestingly, we found that hydrogen therapy induced by our live PSB did not lead to the up-regulation of PD-L1 after stimulating the immune response, which could avoid the tumor immune escape.

conclusionHydrogen-immunotherapy significantly kills tumor cells. We believe that our live microbial hydrogen production system provides a new strategy for cancer hydrogen treatment combining with enhanced immunotherapy without up-regulating PD-L1.

Indexed as

B7-H1 AntigenNeoplasmsCD8-Positive T-LymphocytesHumansHydrogenImmunotherapyB7-H1 AntigenHydrogenHydrogen therapyImmune escapedImmunotherapyOxidative stressPhotosynthetic bacteria

Identifiers

PMID35705974
PMCPMC9199139
OpenAlexW4282930515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.